The hypothesis of these central leptin actions through this system seems to be reasonable, since the signaling of leptin in serotonergic neurons of ventromedial hypothalamus recruits two mediators to inhibit bone mass accrual, CART and the SNS [262], also supported by the clinical observation that patients with high sympathetic activity develop severe osteoporosis. The gene discussed is LEP; the disease is osteoporosis.